Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Photobiomodulation Therapy Using the MuReva Phototherapy System to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Patients With Head and Neck Cancer Receiving Radiation Therapy With or Without Concurrent Chemotherapy

NCT03972527 is registered in ClinicalTrials.gov with MuReva Phototherapy Inc. as lead sponsor.

NCT NCT03972527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03972527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Photobiomodulation Therapy Using the MuReva Phototherapy System to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Patients With Head and Neck Cancer Receiving Radiation Therapy With or Without Concurrent Chemotherapy
Lead sponsor
MuReva Phototherapy Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 5, 2022
Completion date
July 18, 2024
Enrollment
85 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, oral mucositis (ulcerative), oral mucositis (ulcerative) due to antineoplastic therapy, oral mucositis (ulcerative) due to radiation